Shennon Biotechnologies

Shennon Biotechnologies is a San Francisco based biotechnology company accelerating drug development by screening millions of single cell-cell interactions to identify novel therapeutic agents for cancer and autoimmune disease. Its proprietary TCELERATOR platform combines ultrafast single cell-cell interaction mapping with proprietary AI models to discover new targets and develop more effective medicines. The company is backed by DCVC and, as of this enrichment pass, publishes a corporate marketing site but no public API, developer portal, SDK, or machine-readable interface.

Shennon Biotechnologies is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Artificial Intelligence, and Immunology.

8.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyDrug DiscoveryArtificial IntelligenceImmunologyOncologySingle CellLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/shennon-biotechnologies: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Other 2

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: shennon-biotechnologies
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/shennon-biotechnologies.png
name: Shennon Biotechnologies
description: Shennon Biotechnologies is a San Francisco based biotechnology company accelerating drug development by screening
  millions of single cell-cell interactions to identify novel therapeutic agents for cancer and autoimmune disease. Its proprietary
  TCELERATOR platform combines ultrafast single cell-cell interaction mapping with proprietary AI models to discover new targets
  and develop more effective medicines. The company is backed by DCVC and, as of this enrichment pass, publishes a corporate
  marketing site but no public API, developer portal, SDK, or machine-readable interface.
url: https://raw.githubusercontent.com/api-evangelist/shennon-biotechnologies/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Drug Discovery
- Artificial Intelligence
- Immunology
- Oncology
- Single Cell
- Life Sciences
apis: []
common:
- type: Website
  url: https://shennonbio.com
- type: Team
  url: https://shennonbio.com/team
- type: Technology
  url: https://shennonbio.com/technology
- type: Careers
  url: https://shennonbio.com/careers
- type: Contact
  url: https://shennonbio.com/contact-us
- type: PrivacyPolicy
  url: https://shennonbio.com/privacy-policy
- type: LinkedIn
  url: https://www.linkedin.com/company/shennon-bio/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 0
  pass: local-v1